Related Experiment Videos

Serum group I pepsinogens level in cystic fibrosis

Insights

Patients with cystic fibrosis have higher fasting serum pepsinogen 1 levels. The cause of this increase in pepsinogen 1, a key digestive enzyme, remains unknown in cystic fibrosis patients.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Gastroenterology

Background:

  • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
  • Pepsinogen 1 is a precursor to pepsin, a digestive enzyme.
  • Altered gastrointestinal function is common in CF.

Purpose of the Study:

  • To investigate serum pepsinogen 1 levels in children with cystic fibrosis.
  • To compare these levels with age-matched healthy controls.

Main Methods:

  • Radioimmunoassay was used to measure fasting serum pepsinogen 1.
  • 30 patients with cystic fibrosis and 30 healthy children were studied.

Main Results:

  • Serum pepsinogen 1 levels were significantly higher in cystic fibrosis patients (49 +/- 18 ng/ml) compared to controls (38 +/- 12 ng/ml).
  • No correlation was found between elevated pepsinogen 1 and oxygen/carbon dioxide levels, fat balance, or acid output.

Conclusions:

  • Elevated serum pepsinogen 1 is observed in cystic fibrosis patients.
  • The underlying mechanisms for this elevation are currently unknown.
  • These findings may offer insights into the pathophysiology of cystic fibrosis.

Related Concept Videos